Botulinum Toxin for the Treatment of Myofascial Pain Syndromes Involving the Neck and Back: A Review from a Clinical Perspective

Introduction. Botulinum toxin inhibits acetylcholine (ACh) release and probably blocks some nociceptive neurotransmitters. It has been suggested that the development of myofascial trigger points (MTrP) is related to an excess release of ACh to increase the number of sensitized nociceptors. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Climent, José M., Kuan, Ta-Shen, Fenollosa, Pedro, Martin-del-Rosario, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590763/
https://www.ncbi.nlm.nih.gov/pubmed/23533477
http://dx.doi.org/10.1155/2013/381459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590763/
https://www.ncbi.nlm.nih.gov/pubmed/23533477
http://dx.doi.org/10.1155/2013/381459

Ejemplares similares